Cargando…
New strategies for Alzheimer disease and cognitive impairment
Approximately five million people suffer with Alzheimer disease (AD) and more than twenty-four million people are diagnosed with AD, pre-senile dementia, and other disorders of cognitive loss worldwide. Furthermore, the annual cost per patient with AD can approach $200,000 with an annual population...
Autores principales: | Maiese, Kenneth, Chong, Zhao Zhong, Hou, Jinling, Shang, Yan Chen |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2835916/ https://www.ncbi.nlm.nih.gov/pubmed/20716915 |
Ejemplares similares
-
A fork in the path: Developing therapeutic inroads with FoxO proteins
por: Maiese, Kenneth, et al.
Publicado: (2009) -
The Vitamin Nicotinamide: Translating Nutrition into Clinical Care
por: Maiese, Kenneth, et al.
Publicado: (2009) -
Therapeutic promise and principles: Metabotropic glutamate receptors
por: Maiese, Kenneth, et al.
Publicado: (2008) -
Erythropoietin, Forkhead Proteins, and Oxidative Injury: Biomarkers and Biology
por: Maiese, Kenneth, et al.
Publicado: (2009) -
Wnt1 neuroprotection translates into improved neurological function during oxidant stress and cerebral ischemia through AKT1 and mitochondrial apoptotic pathways
por: Chong, Zhao Zhong, et al.
Publicado: (2010)